Ironwood Pharmaceuticals (IRWD) Revenue (2016 - 2025)
Historic Revenue for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $122.1 million.
- Ironwood Pharmaceuticals' Revenue rose 3326.49% to $122.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.0 million, marking a year-over-year decrease of 1042.0%. This contributed to the annual value of $351.4 million for FY2024, which is 2062.75% down from last year.
- Per Ironwood Pharmaceuticals' latest filing, its Revenue stood at $122.1 million for Q3 2025, which was up 3326.49% from $85.2 million recorded in Q2 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' Revenue peaked at $122.1 million during Q3 2025, and registered a low of $41.1 million during Q1 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' median Revenue value was $103.7 million (recorded in 2021), while the average stood at $98.3 million.
- Over the last 5 years, Ironwood Pharmaceuticals' Revenue had its largest YoY gain of 3326.49% in 2025, and its largest YoY loss of 4505.26% in 2025.
- Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Revenue stood at $117.1 million in 2021, then decreased by 8.48% to $107.2 million in 2022, then increased by 9.66% to $117.6 million in 2023, then dropped by 22.98% to $90.5 million in 2024, then soared by 34.81% to $122.1 million in 2025.
- Its Revenue stands at $122.1 million for Q3 2025, versus $85.2 million for Q2 2025 and $41.1 million for Q1 2025.